Elevance Health Shares Drop 1.75% on $620M Volume Rank 177th as Dividend Contender Approaches Ex-Date

On September 8, 2025, , ranking 177th in market activity. The stock entered ex-dividend status on September 10, . , potentially impacting early trading dynamics. Elevance has maintained 14 consecutive years of dividend increases, positioning it as a "future dividend aristocrats contender" in the S&P 1500.

The company's consistent dividend growth trajectory underscores its appeal to income-focused investors. Historical data shows ELV has demonstrated dividend stability over time, . However, market reactions to ex-dividend dates remain subject to broader market conditions and investor sentiment, which may amplify or mitigate typical price adjustments.

To set up this I need to pin down a few practical details: 1. Stock universe • Which market(s) should be scanned each day for the “top-500-by-volume” list? • If you have a ready-made symbol list (e.g., all constituents of the S&P 500, all US common stocks, a particular exchange, etc.), please let me know. 2. Price for execution • Entry at that day’s close and exit at next day’s close is the most common convention. Is that acceptable? • If you prefer open-to-open, open-to-close, etc., please specify. 3. / slippage (optional) • Should we include an assumed commission or bid-ask spread? If so, at what rate? 4. (optional) • Any stop-loss, take-profit or maximum holding-days constraints beyond the 1-day holding period?